Mail

UK markets closed

FTSE 100
8,414.99
-18.77(-0.22%)
FTSE 250
20,560.34
-85.04(-0.41%)
AIM
787.02
-2.85(-0.36%)
GBP/EUR
1.1632
+0.0010(+0.08%)
GBP/USD
1.2555
+0.0031(+0.24%)
Bitcoin GBP
50,222.46
+1,288.11(+2.63%)

Trending tickers: Alibaba, Bitcoin, SoftBank and Diploma

The latest investor updates on stocks that are trending on Monday

Weihai Baihe Biology Technological Co., Ltd. (603102.SS)

Shanghai - Shanghai Delayed price. Currency in CNY

Add to watchlist

34.76

-1.14

(-3.18%)

At close: 03:00PM CST

Currency in CNY

Valuation measures⁴

Market cap (intra-day)	2.30B
Enterprise value	1.21B
Trailing P/E	14.48
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	2.78
Price/book (mrq)	1.48
Enterprise value/revenue	2.41
Enterprise value/EBITDA	11.45

Trading information

Stock price history

Beta (5Y monthly)	0.70
52-week change ³	-18.35%
S&P500 52-week change ³	26.27%
52-week high ³	48.98
52-week low ³	29.03
50-day moving average ³	35.14
200-day moving average ³	39.46

Share statistics

Avg vol (3-month) ³	830.15k
Avg vol (10-day) ³	985.12k
Shares outstanding ⁵	64M
Implied shares outstanding ⁶	64M
Float ⁸	26.71M
% held by insiders ¹	60.46%
% held by institutions ¹	3.44%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.6
Forward annual dividend yield ⁴	1.67%
Trailing annual dividend rate ³	0.75
Trailing annual dividend yield ³	2.09%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	24.19%
Dividend date ³	N/A
Ex-dividend date ⁴	16 May 2023
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	19.22%
Operating margin (ttm)	21.30%

Management effectiveness

Return on assets (ttm)	5.70%
Return on equity (ttm)	10.55%

Income statement

Revenue (ttm)	827.93M
Revenue per share (ttm)	12.90
Quarterly revenue growth (yoy)	-18.70%
Gross profit (ttm)	N/A
EBITDA	193.5M
Net income avi to common (ttm)	159.13M
Diluted EPS (ttm)	2.48
Quarterly earnings growth (yoy)	-22.20%

Balance sheet

Total cash (mrq)	1.09B
Total cash per share (mrq)	17.04
Total debt (mrq)	1.79M
Total debt/equity (mrq)	0.12%
Current ratio (mrq)	7.51
Book value per share (mrq)	24.20

Cash flow statement

Operating cash flow (ttm)	210.36M
Levered free cash flow (ttm)	64.69M